[ad_1]
CUHK Innovation Restricted has introduced its funding in BioMed, marking its first funding since its institution. Pictured are Mr. Vincent Tsang, CEO and Co-founder of BioMed (second from the left), Dr. Norman Chan, Chairman of CUHK Innovation Restricted (third from the left), Ms. Cindy Chow, Director of CUHK Innovation Restricted (second from the best), and Professor Stephen Tsui, Co-founder of BioMed and Affiliate Director (Analysis) of College of Biomedical Sciences, CUHK (first from the best).
BioMed Know-how Holdings Restricted, a startup nurtured by Hong Kong Science Park, was based by a bunch of CUHK professors and alumni. The corporate makes a speciality of microbiology and bioinformatics and is devoted to selling exact and customized microbiome-based interventions. These interventions are designed to revive the stability of the oral, pores and skin, and intestine microbiomes, thereby bettering each bodily and psychological well being.
So far, BioMed has efficiently constructed a microbiome database comprising over 10,000 knowledge factors gathered from various areas throughout Asia. This precious database continues to develop and serves as a promising cornerstone for the corporate’s future R&D endeavors.
Commercially, BioMed has established collaborations with over 200 healthcare service suppliers in Hong Kong and straight markets its merchandise like E3 probiotics and EC Cream to shoppers by greater than 260 shops below the PGut Model. Moreover, the corporate has additionally expanded its operations to Macau, Mainland China, and Thailand.
Managing Director and Chief Funding Officer of CUHK Innovation Restricted, Ms Joyce Ng, ” Individuals are important constructing blocks for enterprise success. The founders of this firm comprise professionals from various fields who’ve sturdy ties to CUHK. These embody Professor Tsui Kwok-Wing Stephen, a professor within the College of Biomedical Sciences and director of the Hong Kong Bioinformatics Centre and the Centre for Microbial Genomics and Proteomics at CUHK, Dr. Steven Bathroom, a dermatologist and Scientific Assistant Professor (honorary) at CUHK, and Vincent Tsang, a serial entrepreneur and CUHK alumnus. By combining their experience, we consider they’ll drive innovation and commercialisation to ship subsequent technology of customerized options to shoppers.”
Medical director and co-founder of BioMed, Dr. Steven Bathroom acknowledged, “We’re honored to be the primary firm to obtain funding from the newly established CUHK Innovation Restricted. This partnership will present us with invaluable help and entry to CUHK’s strong ecosystem, enabling us to speed up our analysis and improvement initiatives and increase our market presence. With the backing of the CUHK Innovation Restricted, we’re assured in our capability to take BioMed to new heights of innovation and empower people with customized and efficient healthcare options that harness the potential of the microbiome.”
As a part of its strategic enlargement, BioMed has just lately launched a pioneering initiative within the quickly rising pet healthcare market. It has joined forces with PetSpace, the main veterinary group in Hong Kong, to conduct a large-scale analysis challenge recruiting a complete of 500 felines and canines. This collaboration has positioned BioMed as the first repository of pet microbiome knowledge in Hong Kong. BioMed and PSG Vivet, a veterinarian-led product improvement firm, have shaped a strategic partnership to develop intestine microbiome checks and customized probiotics for pets. The merchandise are anticipated to launch in Q3 2024.
Chief Govt Officer and co-founder of BioMed, Mr. Vincent Tsang stated,”Via the help of the CUHK Innovation Restricted, BioMed has fortified its capabilities in offering microbiome-based options for human and veterinary healthcare. Our unwavering dedication to superior expertise, scientific analysis, and customized well being administration positions us with utmost confidence to drive innovation and ship distinctive outcomes.”
Hashtag: #BioMedTechnology #BioMed #SciencePark #microbiome #probiotics #CUHKInnovation
https://biomed.hk/
https://www.fb.com/PGUT.HK/
https://www.instagram.com/pgut_hk
The issuer is solely chargeable for the content material of this announcement.
About BioMed Know-how Holdings Restricted
BioMed Know-how Holdings Restricted (BioMed), a startup nurtured by Hong Kong Science Park, was based by a bunch of CUHK professors and alumni. It advocates exact and personalised microbiome-based healthcare options based mostly on DNA testing outcomes, to revive the stability of oral, pores and skin and intestine microbiome.
BioMed has raised funds in its oversubscribed seed spherical from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Companions GBA, The Worldwide Medical Co. Ltd. (TIMC) and Human Well being Holdings Restricted (1419.HK). DSS (NYEX: DSS), a US listed firm can be a shareholder of BioMed. https://biomed.hk/
About CUHK Innovation Restricted
CUHK Innovation Restricted is a newly established firm wholly owned by CUHK to make investments in modern enterprise and impression ventures associated to CUHK’s technological improvements. CUHK Innovation Restricted will begin with an early-stage fund, with a deal with looking for matching funds from enterprise capital traders.
The Firm is dedicated to supporting CUHK’s spin-off firms as they commercialise their modern analysis and improvement achievements, and furthering the College’s mission in selling and enhancing entrepreneurial tradition. https://cuhkinnovation.hk/
[ad_2]
Source link
